Documentation
Real-world efficacy and safety of ocrelizumab in Belgium in PPMS patients according to the prevailing reimbursement criteria
Last updated: 2023-02-03 03:36
Notification of adverse drug reactions of medicines by healthcare professionals and patients
Last updated: 2023-02-03 03:36